(Q33886910)

29 July 2017

3 references

13 March 2019

30 June 2019

17 November 2019

0 references

Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis (English)

1 reference

29 July 2017

main subject

IgA glomerulonephritis

4 references

13 March 2019

30 June 2019

17 November 2019

29 May 2020

1 reference

17 November 2019

Yu-Hao Zhou

1

1 reference

29 July 2017

Li-Gong Tang

2

1 reference

29 July 2017

Shi-Lei Guo

3

1 reference

29 July 2017

Zhi-Chao Jin

4

1 reference

29 July 2017

Mei-Jing Wu

5

1 reference

29 July 2017

Jia-Jie Zang

6

1 reference

29 July 2017

Jin-Fang Xu

7

1 reference

29 July 2017

Chun-Fang Wu

8

1 reference

29 July 2017

Ying-Yi Qin

9

1 reference

29 July 2017

Qing Cai

10

1 reference

29 July 2017

Qing-Bin Gao

11

1 reference

29 July 2017

Shan-Shan Zhang

12

1 reference

29 July 2017

Dand-Hui Yu

13

1 reference

29 July 2017

Jia He

14

1 reference

29 July 2017

language of work or name

English

0 references

publication date

12 April 2011

5 references

29 July 2017

13 March 2019

30 June 2019

17 November 2019

29 May 2020

4 references

29 July 2017

13 March 2019

30 June 2019

17 November 2019

6

1 reference

29 July 2017

issue

4

1 reference

29 July 2017

page(s)

e18788

1 reference

Creative Commons Attribution 4.0 International

29 July 2017

copyright license

3 references

13 March 2019

30 June 2019

on focus list of Wikimedia project

17 November 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Attention should be given to multiplicity issues in systematic reviews

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

The improvement of renal survival with steroid pulse therapy in IgA nephropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

The IgA nephropathy treatment dilemma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

New insights in the pathogenesis of IgA nephropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Clinical trials: where are we now?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Management of IgA nephropathy: evidence-based recommendations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Corticosteroids in IgA nephropathy: a randomised controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

The commonest glomerulonephritis in the world: IgA nephropathy.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Prognostic pathologic markers in IgA nephropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Worldwide perspective of IgA nephropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Effects of steroid therapy in IgA nephropathy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria

5 July 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Role of proteinuria reduction in the progression of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0018788

Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Cellular crescents and segmental glomerular necrosis in IgA nephropathy are indicative of the beneficial effects of corticosteroid therapy.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3075273

Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy

29 October 2018

1 reference

12 December 2020

Treatment options for IgA nephropathy in adults: a proposal for evidence-based strategy

1 reference

12 December 2020

Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial

1 reference

12 December 2020

Proteinuria in IgA nephropathy

1 reference

12 December 2020

IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States?

1 reference

12 December 2020

Effect of corticosteroids on renal function in progressive IgA nephropathy--long-term follow-up study

1 reference

12 December 2020

Double-blind, controlled trial of short-term prednisone therapy in immunoglobulin A glomerulonephritis

1 reference

12 December 2020

Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy

1 reference

12 December 2020

Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial

1 reference

12 December 2020

Treatment of IgA nephropathy in children: efficacy of alternate-day oral prednisone

1 reference

12 December 2020

Treatment of IgA nephropathy

1 reference

12 December 2020

Immunoglobulin a nephropathy with mild renal lesions: a call in the forest for physicians and nephrologists

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0018788

Identifiers

DOI

1 reference

29 July 2017

0 references

1 reference

29 July 2017

1 reference